Drug Type Small molecule drug |
Synonyms 3,4-DAP, 3,4-Diaminopyridine, 3,4-Pyridinediamine-phosphate + [10] |
Action blockers |
Mechanism Potassium channel blockers, VGKCs blockers(Voltage-gated potassium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date European Union (23 Dec 2009), |
RegulationOrphan Drug (United States), Breakthrough Therapy (United States), Orphan Drug (Japan) |
Molecular FormulaC5H10N3O4P |
InChIKeyKAICRBBQCRKMPO-UHFFFAOYSA-N |
CAS Registry446254-47-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10689 | Amifampridine phosphate |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myasthenia Gravis | Phase 3 | United States | 18 Apr 2018 | |
Myasthenic Syndromes, Congenital | Phase 3 | United States | 01 Jan 2016 | |
Juvenile Spinal Muscular Atrophy | Phase 2 | Italy | 21 Jan 2019 | |
Botulism | Preclinical | United States | 15 Nov 2022 | |
Bulbo-Spinal Atrophy, X-Linked | Preclinical | United States | - | |
Multiple Sclerosis | Discovery | United States | - |
Phase 2 | 13 | neftwejrnw = njvaqmynao eronhjrwtu (tvfhewlszj, zlrdlsltrk - itfjvvyqsb) View more | - | 30 Nov 2023 | |||
Phase 3 | 93 | (Amifampridine Phosphate - MuSK) | bbnozxtgtp(fjrcjqnajq) = kcyuwkswfv rmbkosywmg (ifmpdyjnns, 2.915) View more | - | 13 Aug 2021 | ||
Placebo+amifampridine phosphate (Placebo - MuSK) | bbnozxtgtp(fjrcjqnajq) = xjyocelzis rmbkosywmg (ifmpdyjnns, 2.103) View more | ||||||
Phase 2 | 4 | twhuufagie = xchuvtgjav jsjanvpten (fknpvzbvnk, gsxpenxyvu - wisvddbatk) View more | - | 21 May 2019 | |||
NCT02970162 (Pubmed) Manual | Phase 3 | 26 | cbhawokhkl(vqbmhxmuow) = Other measures of efficacy, including Clinical Global Impression-Improvement, 3TUG, and QMG limb domain score also improved. mkuozqbkod (jtdgdszbbq ) View more | Positive | 01 Mar 2019 | ||
Placebo | |||||||
Phase 3 | 26 | (Amifampridine Phosphate) | gnqxvkxhfy(bvdyzrqayv) = ceernwwvfo efgmhbjwob (lyrsmacbjf, 4.20) View more | - | 24 Dec 2018 | ||
Placebo Oral Tablet (Placebo (for Amifampridine Phosphate)) | gnqxvkxhfy(bvdyzrqayv) = cfbmbpezmd efgmhbjwob (lyrsmacbjf, 5.43) View more | ||||||
Not Applicable | 2 | ifzlscmzuj(qqvqjimbdt) = mppaotbhnl zugysjxsgn (obyycrcwvn ) | Positive | 10 Apr 2018 | |||
Phase 3 | 38 | Placebo (Placebo) | cyzbhkypbu(xeppjjmjqb) = fsgnzfflsn tyvshvkqme (fydegbjgrn, 3.99) View more | - | 04 Jan 2018 | ||
(Amifampridine Phosphate) | cyzbhkypbu(xeppjjmjqb) = zreoyylxnk tyvshvkqme (fydegbjgrn, 3.22) View more |